SCHEMBL3168115

SCHEMBL3168115

CCc1ccc2cc(-c3ccccc3)ccc2c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.67
CYP2A6 P11509 1/20 0.67
ESR1 P03372 3/20 0.52
ESR2 Q92731 3/20 0.52
BCL2 P10415 1/20 0.50
PTGS2 P35354 1/20 0.45
AKR1C3 P42330 1/20 0.45
AKR1C2 P52895 1/20 0.45
TP53 P04637 1/20 0.44
TAAR1 Q96RJ0 2/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
FFAR4 Q5NUL3 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
BACE1 P56817 1/20 0.42
MAPKAPK2 P49137 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
PGR P06401 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28802323 0.94 CYP1A2 (0.64) CYP1A2CYP2A6ESR1ESR2BCL2
SCHEMBL28146599 0.85 CYP2A6 (0.54) CYP1A2CYP2A6ESR1ESR2BCL2
SCHEMBL3162554 0.85 ESR1 (0.48) CYP1A2CYP2A6ESR1ESR2TAAR1
SCHEMBL3164981 0.84 CYP1A2 (0.55) CYP1A2CYP2A6ESR1ESR2BCL2
SCHEMBL10978891 0.84 CYP1A2 (0.61) CYP1A2CYP2A6ESR1ESR2BCL2
SCHEMBL3158271 0.84 TAAR1 (0.59) CYP1A2CYP2A6ESR2BCL2PTGS2
SCHEMBL3958297 0.82 CYP1A2 (0.53) CYP1A2CYP2A6BCL2AKR1C3AKR1C2
SCHEMBL3167440 0.82 CYP1A2 (0.53) CYP1A2CYP2A6BCL2AKR1C3AKR1C2
SCHEMBL3157962 0.82 CYP1A2 (0.53) CYP1A2CYP2A6BCL2PTGS2AKR1C3
SCHEMBL27522450 0.82 HRH3 (0.54) CYP1A2CYP2A6BCL2AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP claimed
EP-1452514-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2010-03-31 EP disclosed
EP-1273562-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2009-07-22 EP disclosed
CN-1291958-C Naphthacridine derivative and liquid crystal composite containing it DAINIPPON INK CHEMICAL IND CO (JP) 2006-12-27 CN disclosed
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed
EP-0952135-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 1999-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 CYP1A2 959/4885CYP2A6 3496/4885ESR1 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.